“Design And Synthesis Of 3-Arylcoumerin Derivatives As A Selective Mao-B Inhibitor”, Journal of Pharmaceutical Negative Results, pp. 9820–9833, Dec. 2022, doi: 10.47750/pnr.2022.13.S09.1147.